MIT

Author page description

August 13

  • MIT gears up to transform manufacturing

    ➀ MIT launched the Initiative for New Manufacturing (INM) to drive technological innovation, talent development, and scalable production systems;

    ➁ INM collaborates with industry giants like Amgen, Siemens, and Flex on AI/automation integration and workforce training;

    ➂ The initiative emphasizes revitalizing U.S. manufacturing through technology adoption, cross-sector partnerships, and advocacy for manufacturing careers.

    AmgenAutodeskFlex

April 4

April 3

March 28

March 17

March 4

  • Designing better ways to deliver drugs
    ➀ Louis DeRidder's near-death experience at 12 sparked his interest in medicine; ➁ His high school program led to a deep fascination with drug delivery to the brain; ➂ DeRidder's research at Johns Hopkins University focused on nanoparticle-drug conjugates for neurodegenerative diseases; ➃ At Harvard-MIT, he developed CLAUDIA, a device for personalized drug dosing during chemotherapy; ➄ DeRidder's work involves MATLAB and Simulink for modeling drug pharmacokinetics; ➅ He aims to move CLAUDIA towards clinical use and potentially start a company for commercialization; ➆ In addition, DeRidder is developing new nanoparticles for therapeutic nucleic acid delivery; ➇ He balances research with community service, helping the homeless in Boston; ➈ His long-term goals include developing treatments for neurological diseases and cancer.
    Harvard-MIT Health Sciences and TechnologyJohns Hopkins UniversityMathWorks

January 7

January 4

November 21

  • Tunable ultrasound propagation in microscale metamaterials
    ➀ Researchers from MIT and other institutions have developed a design framework for controlling ultrasound wave propagation in microscale acoustic metamaterials; ➁ The framework involves precisely positioning microscale spheres to tune how ultrasound waves travel through 3D microscale metamaterials; ➂ The work enables tunable elastic-wave velocities within microscale materials and demonstrates an acoustic demultiplexer, paving the way for microscale devices useful for ultrasound imaging or information transmission.
    MITScience Advancesmechanical engineering

November 19

November 4

October 31

  • “Wearable” devices for cells
    ➀ MIT researchers develop wearable devices for individual cells; ➁ These subcellular-sized devices are battery-free and made of a soft polymer; ➂ They can measure or modulate a neuron’s electrical and metabolic activity at a subcellular level.
    MITNeuronsWearable Devices

October 15

October 11

October 6

  • Modeling Relationships to Solve Complex Problems Efficiently
    ➀ Associate Professor Julian Shun develops high-performance algorithms and frameworks for large-scale graph processing; ➁ His work focuses on finding the shortest path between objects in a network and detecting fraudulent transactions; ➂ Shun's algorithms leverage parallel computing to analyze massive graphs efficiently; ➃ He has developed user-friendly programming frameworks to facilitate efficient graph algorithm development; ➄ Shun's research includes clustering algorithms and dynamic graph algorithms for real-world applications.
    High-Performance Computing

July 30

  • MIT spinout Arnasi begins applying LiquiGlide no-stick technology to help patients
    ➀ Arnasi Group, formerly known as LiquiGlide, is developing biomedical products leveraging their no-stick technology; ➁ Their first product, Revel, is a lubricant for ostomy pouches, simplifying the cleaning process and preventing clogging; ➂ Revel has received positive feedback from nurses and patients, and the company plans to apply the technology to prevent infections in implants and catheters, and to assist those with cystic fibrosis.

June 16

  • A new way to spot life-threatening infections in cancer patients
    1. Chemotherapy and other treatments can destroy immune cells, leading to potentially deadly infections in cancer patients with weakened immune systems. 2. Leuko is developing an at-home white blood cell monitor that uses light and artificial intelligence to detect dangerously low white blood cell levels without drawing blood. 3. The technology was conceived by MIT researchers in 2015, and Leuko's devices have accurately detected low white blood cell counts in hundreds of cancer patients. 4. The company has been working with the FDA to confirm the accuracy and ease of use of their device, expecting to begin a pivotal study for FDA approval later this year. 5. Leuko's team believes the device could optimize cancer treatment by personalizing chemotherapy doses based on individual patient reactions. 6. The device could also be used to monitor immune health in other patient populations, such as those with multiple sclerosis, autoimmune diseases, organ transplants, and emergency room patients. 7. The company envisions the device as a platform technology for measuring other blood parameters beyond white blood cells in the future.
    FDALeukoMIT

March 28

  • VIAVI Solutions joins MIT.nano Consortium
    1. VIAVI Solutions, a global provider of communication test and measurement and optical technologies, has joined the MIT.nano Consortium. 2. VIAVI's history dates back to 1923 and 1948, and it supports innovation in various fields such as communication networks and consumer electronics. 3. VIAVI will contribute global insights to the MIT.nano Consortium and collaborate on innovations in materials and processes for future photonics applications. 4. The MIT.nano Consortium facilitates academic-industry collaboration and includes other companies like Analog Devices, IBM Research, and Lockheed Martin.
    MIT.nano ConsortiumVIAVI Solutions